Acella Pharmaceuticals Overview
- Year Founded
-
2007

- Status
-
Private
- Employees
-
59

- Latest Deal Type
-
Debt Repay.
Acella Pharmaceuticals General Information
Description
Manufacturer and distributor of specialty pharmaceuticals. The company offers pharmaceuticals for women's health, pain relief, nutritional supplementation, endocrinology, injectables, dermatology, cough and cold.
Contact Information
Website
www.acellapharma.comCorporate Office
- 1880 McFarland Parkway
- Suite 110-B
- Alpharetta, GA 30005
- United States
Corporate Office
- 1880 McFarland Parkway
- Suite 110-B
- Alpharetta, GA 30005
- United States
Acella Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Debt Repayment | 30-Sep-2013 | Completed | Generating Revenue | |||
2. Debt - General | 31-Dec-2012 | Completed | Generating Revenue | |||
1. Debt - Acquisition | 04-Jan-2012 | $65M | Completed | Generating Revenue |
Acella Pharmaceuticals Comparisons
Industry
Financing
Details
Acella Pharmaceuticals Competitors (9)
One of Acella Pharmaceuticals’s 9 competitors is GlaxoSmithKline Consumer Nigeria, a Corporation company based in Lagos, Nigeria.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | ||||
Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
Glaxosmithkline Consumer Healthcare | Corporate Backed or Acquired | Gurugram, India | ||||
Novartis | Corporation | Basel, Switzerland | ||||
Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel |
Acella Pharmaceuticals Patents
Acella Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190167654-A1 | Dose-dumping resistant controlled release dosage form | Active | 08-Feb-2017 | ||
US-10265308-B2 | Dose-dumping resistant controlled release dosage form | Active | 08-Feb-2017 | ||
US-20180221360-A1 | Dose-dumping resistant controlled release dosage form | Active | 08-Feb-2017 | ||
CA-2992767-C | Dose-dumping resistant controlled release dosage form | Active | 03-Feb-2017 | ||
CA-2992767-A1 | Dose-dumping resistant controlled release dosage form | Active | 03-Feb-2017 | A61K31/4458 |
Acella Pharmaceuticals Signals
Acella Pharmaceuticals Investments (1)
Acella Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with International Vitamin (Generic Rx Portfolio). The deal was made on 20-May-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
International Vitamin (Generic Rx Portfolio) | 20-May-2020 | Corporate Asset Purchase | Buildings and Property |
Acella Pharmaceuticals FAQs
-
When was Acella Pharmaceuticals founded?
Acella Pharmaceuticals was founded in 2007.
-
Where is Acella Pharmaceuticals headquartered?
Acella Pharmaceuticals is headquartered in Alpharetta, GA.
-
What is the size of Acella Pharmaceuticals?
Acella Pharmaceuticals has 59 total employees.
-
What industry is Acella Pharmaceuticals in?
Acella Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Acella Pharmaceuticals a private or public company?
Acella Pharmaceuticals is a Private company.
-
What is Acella Pharmaceuticals’s current revenue?
The current revenue for Acella Pharmaceuticals is
. -
How much funding has Acella Pharmaceuticals raised over time?
Acella Pharmaceuticals has raised $60.9M.
-
Who are Acella Pharmaceuticals’s competitors?
GlaxoSmithKline Consumer Nigeria, Pfizer Manufacturing Austria, Glaxosmithkline Consumer Healthcare, Novartis, and Teva Pharmaceutical Industries are some of the 9 competitors of Acella Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »